Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 301–400 of 999
Butt, J., Jenab, M., Werner, J., Fedirko, V., Weiderpass, E., Dahm, C. C., Tjønneland, A. M., Olsen, A., Boutron‐Ruault, M., Rothwell, J. A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1903825 · Cited by 51
“coli and ETBF in tumor tissue of CRC patients with FAP.(21) In our study, information on this inherited condition is unavailable and it is not likely to be present in more than a few cases.”
BackgroundResultInfluentialD’Souza, S. M., Houston, K. V., Keenan, L., Yoo, B. S., Parekh, P. J., & Johnson, D. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i18.2054 · Cited by 55
Sun, H. J., Zhang, H., Zhang, A., Zhou, X., Wang, X., Han, Y., Yan, G., Liu, L., & Wang, X. (2018) · RSC Advances · doi:10.1039/c8ra04886j · Cited by 45
Interaction between microbiota and immunity and its implication in colorectal cancer
Xing, C., Du, Y., Duan, T., Nim, K., Chu, J., Wang, H. Y., & Wang, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963819 · Cited by 52
Self-citationExpansion of Colorectal Cancer Biomarkers Based on Gut Bacteria and Viruses
Zhang, J., He, Y., Xia, L., Yi, J., Wang, Z., Zhao, Y., Song, X., Li, J., Liu, H., Liang, X., et al. (2022) · Cancers · doi:10.3390/cancers14194662 · Cited by 50
Shaw, D. G., Aguirre‐Gamboa, R., Vieira, M. C., Gona, S., DiNardi, N., Wang, A., Dumaine, A., Gelderloos-Arends, J., Earley, Z. M., Meckel, K. R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02372-x · Cited by 48
Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic Strategies
Jandl, B., Dighe, S. N., Baumgartner, M., Makristathis, A., Gasché, C., & Muttenthaler, M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.032 · Cited by 57
The Four Horsemen in Colon Cancer
Hernández-Luna, M. A., López-Briones, S., & Luría-Pérez, R. (2019) · Journal of Oncology · doi:10.1155/2019/5636272 · Cited by 50
“coli pks+ strains have been found simultaneously in patients with adenomatous polyps, a precursor lesion of colon cancer [147].”
Qian, W., Zhang, J., Wang, W., Wang, T., Liu, M., Yang, M., Sun, Z., Li, X., & Li, Y. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14480 · Cited by 47
Gut microecology: Why our microbes could be key to our health
Lu, D., Huang, Y., Kong, Y., Tao, T., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110784 · Cited by 49
Wang, C., Li, S., Hong, K., Yu, L., Tian, F., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2021) · Food & Function · doi:10.1039/d1fo00875g · Cited by 47
Zhang, H., Hu, Q., Zhang, Y., Yang, L., Tian, S., Zhang, X., Shen, H., Shu, H., Xie, L., Wu, D., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2517821 · Cited by 50
“35 Zhang et al. demonstrated that the Lachnospiraceae family enhances the immunosurveillance function of CD8+ T cells and controls colorectal cancer progression.”
Self-citationTeh, W. K., Dramsi, S., Tolker‐Nielsen, T., Yang, L., & Givskov, M. (2019) · Journal of Bacteriology · doi:10.1128/jb.00597-18 · Cited by 45
Park, H. B., Wei, Z., Oh, J., Xu, H. Y., Kim, C. S., Wang, R., Wyche, T. P., Piizzi, G., Flavell, R. A., & Crawford, J. M. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0763-4 · Cited by 43
Deciphering Human Microbiota–Host Chemical Interactions
Silpe, J. E., & Balskus, E. P. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01030 · Cited by 45
Qu, D., Sun, F., Feng, S., Yu, L., Tian, F., Zhang, H., Chen, W., & Zhai, Q. (2022) · Food & Function · doi:10.1039/d1fo03073f · Cited by 46
Common themes in antimicrobial and anticancer drug resistance
Chifiriuc, M. C., Filip, R., Constantin, M., Pîrcălăbioru, G. G., Bleoţu, C., Burlibaşa, L., Ionica, E., Corcionivoschi, N., & Mihăescu, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.960693 · Cited by 41
Su, Y., & Ding, T. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2252780 · Cited by 45
Dalmasso, G., Cougnoux, A., Faïs, T., Bonnin, V., Mottet-Auselo, B., Nguyen, H. T. T., Sauvanet, P., Barnich, N., Jary, M., Pezet, D., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2310215 · Cited by 45
Gut γδ T cells as guardians, disruptors, and instigators of cancer
Suzuki, T., Hayman, L., Kilbey, A., Edwards, J., & Coffelt, S. B. (2020) · Immunological Reviews · doi:10.1111/imr.12916 · Cited by 45
Tang-Fichaux, M., Chagneau, C. V., Bossuet‐Greif, N., Nougayrède, J., Oswald, É., & Branchu, P. (2020) · mSphere · doi:10.1128/msphere.01195-20 · Cited by 48
“coli has been found in inflammatory bowel disease (IBD) and colorectal cancer (CRC) patients (12, 15, 16).”
BackgroundProfiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer
Okuda, S., Shimada, Y., Tajima, Y., Yuza, K., Hirose, Y., Ichikawa, H., Nagahashi, M., Sakata, J., Ling, Y., Miura, N., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.049 · Cited by 45
“Enterotoxigenic Bacteroides fragilis (ETBF) and genotoxic pks + Escherichia coli, which produce a cyclomodulin toxin called colibactin, were also associated with DNA damage in CRC [19,20].”
BackgroundYu, L. C., Wei, S., Li, Y.-H., Lin, P.-Y., Chang, X., Weng, J.-P., Shue, Y.-W., Lai, L., Wang, J., Jeng, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.007 · Cited by 40
The pks island: a bacterial Swiss army knife? Colibactin: beyond DNA damage and cancer
Chagneau, C. V., Payros, D., Tang-Fichaux, M., Auvray, F., Nougayrède, J., & Oswald, É. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.05.010 · Cited by 46
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 54
Li, Q., Peng, W., Wu, J., Wang, X., Ren, Y., Li, H., Peng, Y., Tang, X., & Fu, X. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1626192 · Cited by 44
Martin, O. C. B., Bergonzini, A., D’Amico, F., Chen, P., Shay, J. W., Dupuy, J., Svensson, M., Masucci, M. G., & Frisan, T. (2019) · Cellular Microbiology · doi:10.1111/cmi.13099 · Cited by 47
Growth rate alterations of human colorectal cancer cells by 157 gut bacteria
Taddese, R., Garza, D. R., Ruiter, L. N., de Jonge, M. I., Belzer, C., Aalvink, S., Nagtegaal, I. D., Dutilh, B. E., & Boleij, A. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1799733 · Cited by 47
Self-citationAllen, J., Huber, A. R., Pleguezuelos‐Manzano, C., Puschhof, J., Wu, S., Wu, X., Boot, C., Saftien, A., O’Hagan, H. M., Wang, H., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01055-22 · Cited by 50
Self-citationQueen, J., Zhang, J., & Sears, C. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1706425 · Cited by 52
“Furthermore, we and others have linked the acquisition of carcinogenic microbes or development of colon mucosal biofilms with chronic mucosal inflammation and subsequent tumor formation.(8,9,46,47)”
BackgroundSelf-citationFucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases
Hu, M., Zhang, X., Li, J., Chen, L., He, X., & Sui, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.940196 · Cited by 53
Tannic Acid-Modified Silver Nanoparticles for Antibacterial and Anticancer Applications
Ha, W., Yang, J., & Shi, Y. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c01291 · Cited by 44
Unveiling the intratumoral microbiota within cancer landscapes
Che, S., Yan, Z., Feng, Y., & Hai, Z. (2024) · iScience · doi:10.1016/j.isci.2024.109893 · Cited by 44
“246 Familial adenomatous polyposis, a precursor to colorectal cancer (CRC), showed potential for early CRC detection through intratumoral E. coli , indicating a pre-cancerous inflammatory state 247 (Figure 10).”
BackgroundOral and intestinal bacterial exotoxins: Potential linked to carcinogenesis
Silbergleit, M., Vasquez, A. A., Miller, C. J., Sun, J., & Kato, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.02.004 · Cited by 43
Yang, Y., Zhao, M., He, X., Wu, Q., Li, D., & Zang, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647481 · Cited by 45
“Pyridostigmine Restructured Gut Microbiota Homeostasis in Diabetic Cardiomyopathy Mice Gut microbes are critical for the intestinal epithelial barrier function and physiological homeostasis maintenance (Dejea et al., 2018).”
BackgroundComputational methods and challenges in analyzing intratumoral microbiome data
Wang, Q., Liu, Z., Ma, A., Li, Z., Liu, B., & Ma, Q. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.01.011 · Cited by 37
Hill, C. A., Casterline, B. W., Valguarnera, E., Hecht, A. L., Shepherd, E. S., Sonnenburg, J. L., & Wardenburg, J. B. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01559-9 · Cited by 40
“Further, the identification of BFT-producing strains adjacent to colonic neoplasms suggests that establishment in the microbiome is a disease determinant for colonic cancer 9 .”
Mruk-Mazurkiewicz, H., Kulaszyńska, M., Czarnecka, W., Podkówka, A., Ekstedt, N., Zawodny, P., Wierzbicka-Woś, A., Marlicz, W. M., Skupin, B., Stachowska, E., et al. (2024) · Nutrients · doi:10.3390/nu16111695 · Cited by 43
“A group of bacteria has been identified whose biofilm and potential to disrupt gut vascular barrier increases the risk of colon cancer [98] and augment liver metastases [99].”
BackgroundMicrobial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate
Pope, J. L., Yang, Y., Newsome, R. C., Sun, W., Sun, X., Ukhanova, M., Neu, J., Issa, J. J., Mai, V., & Jobin, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39887-8 · Cited by 47
Synthesis and reactivity of precolibactin 886
Healy, A. R., Wernke, K. M., Kim, C. S., Lees, N. R., Crawford, J. M., & Herzon, S. B. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0338-2 · Cited by 42
Shelton, C. D., & Byndloss, M. X. (2020) · Infection and Immunity · doi:10.1128/iai.00939-19 · Cited by 47
Chen, J., Li, T., Liang, J., Huang, Q., Huang, J., Ke, Y., & Sun, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112443 · Cited by 42
Pan, S., Guo, Y., Hong, F., Xu, P., & Zhai, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166281 · Cited by 37
Thakur, B. K., Malaisé, Y., Choudhury, S. R., Neustaeter, A., Turpin, W., Streutker, C., Copeland, J. K., Wong, E. O. Y., Navarre, W. W., Guttman, D. S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01938-4 · Cited by 50
“…role of gut microorganisms in CRC initiation and progression is supported in particular by the discovery of various CRC-associated bacteria, including the enterotoxigenic Bacteroides fragilis (ETBF), Helicobacter hepaticus and polyketide synthase-positive ( pks + ) Escherichia coli 11–15 .”
Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
Aguilera-Correa, J. J., Madrazo-Clemente, P., Martínez‐Cuesta, M. C., Peláez, C., Ortíz, A., Sánchez-Niño, M. D., Esteban, J., & Requena, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-48426-4 · Cited by 45
Tomkovich, S., Gharaibeh, R. Z., Dejea, C. M., Pope, J. L., Jiang, J., Winglee, K., Gauthier, J., Newsome, R. C., Yang, Y., Fodor, A. A., et al. (2020) · mSystems · doi:10.1128/msystems.00451-19 · Cited by 42
“All patient tissues were collected as previously described (11, 12, 103).”
Self-citationProbing the tumor micro(b)environment
Atreya, C. E., & Turnbaugh, P. J. (2020) · Science · doi:10.1126/science.abc1464 · Cited by 39
Watanabe, D., Murakami, H., Ohno, H., Tanisawa, K., Konishi, K., Tsunematsu, Y., Sato, M., Miyoshi, N., Wakabayashi, K., Watanabe, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72245-7 · Cited by 39
Debesa-Tur, G., Pérez‐Brocal, V., Ruiz‐Ruiz, S., Castillejo, A., Latorre, A., Soto, J. L., & Moyá, A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79874-y · Cited by 44
The role of gut microbiota in tumorigenesis and treatment
Xu, J., Liu, M.-T., Tao, T., Zhu, X. M., & Fei, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111444 · Cited by 45
Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer
Marzano, M., Fosso, B., Piancone, E., Defazio, G., Pesole, G., & Robertis, M. D. (2021) · Cancers · doi:10.3390/cancers13050996 · Cited by 41
“coli stimulates tumor formation both in vitro and in Familial adenomatous polyposis (FAP) patients in the presence of enterotoxigenic Bacteroides fragilis co-colonization [100,145].”
BackgroundOliero, M., Hajjar, R., Cuisiniere, T., Fragoso, G., Calvé, A., Dagbert, F., Loungnarath, R., Sebajang, H., Schwenter, F., Wassef, R., et al. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00523-y · Cited by 46
“coli mono-colonization [7, 8] and colonization of adenomatous polyposis coli multiple intestinal neoplasia (ApcMin/+) mice with colibactin producing E.”
BackgroundMethodResultInfluentialThe Role of Microbiota-Derived Metabolites in Colorectal Cancer
Duizer, C., & de Zoete, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098024 · Cited by 40
The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
Mima, K., Hamada, T., Inamura, K., Baba, H., Ugai, T., & Ogino, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2269623 · Cited by 43
Mudd, A. M., Gu, T., Munagala, R., Jeyabalan, J., Egilmez, N. K., & Gupta, R. C. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0362 · Cited by 38
“Although much research has been conducted on the role of bacteria on inflammation and carcinogenesis (10, 35, 36), no reports have been published regarding the role of ETBF on the expression of phase I and II enzymes.”
BackgroundChen, J., Byun, H., Liu, R., Jung, I.-J., Pu, Q., Zhu, C. Y., Tanchoco, E., Alavi, S., Degnan, P. H., Ma, A. T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121180119 · Cited by 47
“coli in interspecies biofilms exists in colorectal cancer patients (57), with an interaction between colibactinþ E.”
BackgroundGut microbiota biofilms: From regulatory mechanisms to therapeutic targets
Buret, A. G., & Allain, T. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221743 · Cited by 41
Jiang, M., Yang, Z., Dai, J., Wu, T., Jiao, Z., Yu, Y., Kang, N., Chen, W., & Yang, A. (2023) · MedComm · doi:10.1002/mco2.376 · Cited by 39
Wu-Woods, N. J., Barlow, J. T., Trigodet, F., Shaw, D. G., Romano, A. E., Jabrì, B., Eren, A. M., & Ismagilov, R. F. (2023) · Nature Methods · doi:10.1038/s41592-023-02025-4 · Cited by 46
“In clinical studies, we anticipate that MEM will provide researchers the capability to investigate tumor microbi-omes 2,3,47,48 , mucosal intestinal microbiomes 4,9,12,49–51 , tissue translocation of gut microbes 52,53 and the roles of tissue-associated microbes in complex immune disorders 9,54,55…”
BackgroundExploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis
Ševčíková, A., Mladosievičová, B., Mego, M., & Čierniková, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417199 · Cited by 40
“The authors noted that cigarette smoke caused the disruption of pulmonary barrier integrity, allowing for the translocation of bacterial factors into tumors [100].”
BackgroundZhou, Q., Lei, L., Cheng, J., Chen, J., Du, Y., Zhang, X., Li, Q., Li, C., Deng, H., Wong, C. C., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332193 · Cited by 41
Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids
Wang, Y., Chen, W., Han, Z., Zhang, S., Ji, P., Zhang, C., Liang, J., & Zhang, X. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.012 · Cited by 36
Hamid, M. A., Pammer, L. M., Oberparleiter, S., Günther, M., Amann, A., Gruber, R., Mair, A., Nocera, F. I., Ormanns, S., Zimmer, K., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00892-y · Cited by 50
“In patients with familial adenomatous polyposis, colonic bio fi lms primarily consist of ETBF and pks + E. coli , the latter capable of producing genotoxic colibactin 116 .”
In sickness and health: Effects of gut microbial metabolites on human physiology
Glowacki, R. W. P., & Martens, E. C. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008370 · Cited by 36
“Although the gut microbiome is typically described as being composed of nonharmful or beneficial microorganisms, it is now appreciated that both individual species [8] or multiple community members acting together [9, 10] can exert pathogenic effects, which are often more subtle than those of classical pathogens.”
BackgroundThe effects of biofilms on tumor progression in a 3D cancer-biofilm microfluidic model
Deng, Y., Liu, S. Y., Chua, S. L., & Khoo, B. L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113113 · Cited by 37
Ballén, V., Gabasa, Y., Ratia, C., Sánchez, M., & Soto, S. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.803862 · Cited by 49
Guo, S., Peng, Y., Lou, Y., Cao, L., Liu, J., Lin, N., Cai, S., Kang, Y., Zeng, S., & Yu, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106101 · Cited by 40
Regulation of tissue-resident memory T cells by the Microbiota
Overacre-Delgoffe, A. E., & Hand, T. W. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00491-1 · Cited by 41
Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia
Seely, K. D., Morgan, A. D., Hagenstein, L. D., Florey, G. M., & Small, J. M. (2022) · Cancers · doi:10.3390/cancers14041019 · Cited by 39
Fan, K., Eslick, G. D., Nair, P. M., Burns, G. L., Walker, M. M., Hoedt, E. C., Keely, S., & Talley, N. J. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15851 · Cited by 37
Greathouse, K. L., White, J. R., Padgett, R. N., Perrotta, B. G., Jenkins, G. D., Chia, N., & Chen, J. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000247 · Cited by 35
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 39
“coli-derived colicin causes DNA damage in colonic epithelial cells (30, 31).”
BackgroundGut Microbiota Analysis in Postoperative Lynch Syndrome Patients
Mori, G., Orena, B. S., Cultrera, I., Barbieri, G., Albertini, A. M., Ranzani, G. N., Carnevali, I. W., Tibiletti, M. G., & Pasca, M. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01746 · Cited by 41
“These findings highlight a new link between early carcinogenesis of the colon and bacteria (Dejea et al., 2018).”
BackgroundZhang, H., Hui, D., Li, Y., Xiong, G., & Fu, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01149 · Cited by 27
“At present, the study on the secretion of toxin-activated inflammation by the intestinal flora is the most in-depth study of CRA carcinogenesis (3).”
InfluentialRole of gut microbiota and bacterial metabolites in mucins of colorectal cancer
Ming, G., Yin, W., Zhang, J., Yin, J., Tang, X., Ling, J., Tang, Z., Yin, W., Wang, X., Ni, Q., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1119992 · Cited by 33
“Once these biofilm-positive bacteria invaded the colonic mucosal layer and came into direct contact with mucosal epithelial cells, they could cause CRC development in this population (Dejea et al., 2018).”
BackgroundIntestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities
Jandl, B., Dighe, S. N., Gasché, C., Makristathis, A., & Muttenthaler, M. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-23 · Cited by 39
“Pronounced polymicrobial biofilms have a high prevalence in patients with colorectal cancer (64, 130, 165), and mucus-invasive bacterial biofilms on the colon mucosa are observed in ~50% of cases compared to ~13% of healthy controls (143, 166).”
InfluentialLong, J., Wang, J., Xiao, C., You, F., Jiang, Y., & Li, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01831-3 · Cited by 35
“These results suggest that ETBF enhanced pks + E. coli colonization and DNA damage in colonic epithelial cells [66].”
ResultDolgin, E. (2020) · Nature · doi:10.1038/d41586-020-00199-x · Cited by 37
Jin, H., & Zhang, C. (2020) · Journal of Cancer · doi:10.7150/jca.43561 · Cited by 33
“Research methods of coliform flora [8-9]”
Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites
Han, S., Jing, Z., Wu, Y., Wu, W., & Yang, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s268943 · Cited by 40
“coli) invade the inner layer of intestinal mucus and form a biofilm.(106) These two common bacteria are important promoters of CRC.”
BackgroundJun-min, L., Luo, W., Chen, Q., Chen, X., Zhou, G., & Sun, H. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04385-0 · Cited by 34
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
Biosynthesis and bioactivities of microbial genotoxin colibactins
Tang, J., Liu, X., Ye, W., Li, Z., & Qian, P. (2022) · Natural Product Reports · doi:10.1039/d1np00050k · Cited by 39
Li, C., Lau, H. C.-H., Zhang, X., & Yu, J. Q. (2022) · Biomedicines · doi:10.3390/biomedicines10071710 · Cited by 40
“ApcMin/+ mice [63,64], further indicating that the Apc mutant mouse model can accurately recapitulate human FAP.”
BackgroundChen, Q., Qiao, J., Cao, M., Han, Z., Zeng, X., & Zhang, X. (2023) · Materials Today · doi:10.1016/j.mattod.2023.02.002 · Cited by 35
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 37
Gut fungal mycobiome: A significant factor of tumor occurrence and development
Li, F., Gao, Y., Cheng, W., Su, L., & Yang, R. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216302 · Cited by 37
Masheghati, F., Asgharzadeh, M. R., Jafari, A., Masoudi, N., & Maleki, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122529 · Cited by 39
Colorectal cancer initiation: Understanding early-stage disease for intervention
Jiang, C., Zhou, Q., Yi, K., Yuan, Y., & Xie, X. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216831 · Cited by 44
Physiological drivers of pks+ E. coli in colorectal cancer
Jans, M., & Vereecke, L. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.04.010 · Cited by 38
Hwang, S., Jo, M., Hong, J.-E., Park, C. O., Lee, C.-G., Yun, M., & Rhee, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184560 · Cited by 36
“coli, and/or Fusobacterium nucleatum [11,60,61].”
BackgroundCo‐ and polymicrobial infections in the gut mucosa: The host–microbiota–pathogen perspective
Frisan, T. (2020) · Cellular Microbiology · doi:10.1111/cmi.13279 · Cited by 39
“In both models, co-colonisation is associated with an enhanced morbidity and mortality as well as increased colonic tumorigenesis (Dejea et al., 2018).”
BackgroundInfluentialShen, X., Li, J., Li, J., Zhang, Y., Li, X., Cui, Y., Gao, Q., Chen, X., Chen, Y., & Fang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661048 · Cited by 44
“The ETBFbearing biofilms in colon biopsies from CRC patients susceptibility loci were recently reported to strongly suggest that ETBF plays a key role in CRC development (30).”
BackgroundMasetti, R., D’Amico, F., Zama, D., Leardini, D., Muratore, E., Ussowicz, M., Frączkiewicz, J., Cesaro, S., Caddeo, G., Pezzella, V., et al. (2022) · Cancers · doi:10.3390/cancers14081932 · Cited by 35
“The former is a mucus degrader, previously associated with other pathological conditions, such as inflammatory bowel disease [34], colonic epithelial carcinogenesis [35] and multiple sclerosis [36].”
BackgroundKharofa, J. R., Apewokin, S. K., Alenghat, T., & Ollberding, N. J. (2022) · Cancer Medicine · doi:10.1002/cam4.5197 · Cited by 37
Intratumour microbiome of pancreatic cancer
Guan, S.-W., Lin, Q., & Yu, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.713 · Cited by 45
Altered Gut Microbiota in Patients With Peutz-Jeghers Syndrome
Wan, S., Huang, G., Wang, J.-X., Tian, L., Zuo, X., Li, Y., & Yu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.881508 · Cited by 32
“, 2021), and familial adenomatous polyposis (Dejea et al., 2018).”
Association between gut microbiota and CpG island methylator phenotype in colorectal cancer
Park, P. H., Keith, K., Calendo, G., Jelínek, J., Madžo, J., Gharaibeh, R. Z., Ghosh, J., Sapienza, C., Jobin, C., & Issa, J. J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363012 · Cited by 37
Baas, F. S., Brusselaers, N., Nagtegaal, I. D., Engstrand, L. G., & Boleij, A. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.008 · Cited by 36
Self-citationDoes the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
Yang, J., Yang, Y., Ishii, M., Nagata, M., Aw, W., Obana, N., Tomita, M., Nomura, N., & Fukuda, S. (2020) · Microbes and Environments · doi:10.1264/jsme2.me20037 · Cited by 36
“ETBF and polyketide syn‐ thase (pks) genotoxic island-containing (pks+) E. coli have also been identified as tumorigenic bacteria (Dejea et al., 2018).”
BackgroundInfluential
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.